vs
Side-by-side financial comparison of MONRO, INC. (MNRO) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
MONRO, INC. is the larger business by last-quarter revenue ($293.4M vs $151.7M, roughly 1.9× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 3.8%, a 4.0% gap on every dollar of revenue. On growth, MONRO, INC. posted the faster year-over-year revenue change (-4.0% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $9.1M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -2.7%).
Monro, Inc. is an automotive services company founded and headquartered in Rochester, New York, U.S. As of 2025, Monro has 1,260 locations making them the second-largest automotive services company in North America after Driven Brands by number of locations and by revenue.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
MNRO vs NUTX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $293.4M | $151.7M |
| Net Profit | $11.1M | $11.8M |
| Gross Margin | 34.9% | 30.4% |
| Operating Margin | 6.3% | 20.4% |
| Net Margin | 3.8% | 7.8% |
| Revenue YoY | -4.0% | -41.1% |
| Net Profit YoY | 143.1% | -80.8% |
| EPS (diluted) | $0.35 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $293.4M | $151.7M | ||
| Q3 25 | $288.9M | $267.8M | ||
| Q2 25 | $301.0M | $244.0M | ||
| Q1 25 | $295.0M | $211.8M | ||
| Q4 24 | $305.8M | $257.6M | ||
| Q3 24 | $301.4M | $78.8M | ||
| Q2 24 | $293.2M | $76.1M | ||
| Q1 24 | $310.1M | $67.5M |
| Q4 25 | $11.1M | $11.8M | ||
| Q3 25 | $5.7M | $55.4M | ||
| Q2 25 | $-8.1M | $-17.7M | ||
| Q1 25 | $-21.3M | $21.2M | ||
| Q4 24 | $4.6M | $61.6M | ||
| Q3 24 | $5.6M | $-8.8M | ||
| Q2 24 | $5.9M | $-364.0K | ||
| Q1 24 | $3.7M | $-364.0K |
| Q4 25 | 34.9% | 30.4% | ||
| Q3 25 | 35.7% | 57.8% | ||
| Q2 25 | 35.5% | 51.2% | ||
| Q1 25 | 33.0% | 55.9% | ||
| Q4 24 | 34.3% | 55.0% | ||
| Q3 24 | 35.3% | 27.8% | ||
| Q2 24 | 37.2% | 29.7% | ||
| Q1 24 | 35.5% | 15.1% |
| Q4 25 | 6.3% | 20.4% | ||
| Q3 25 | 4.4% | 48.7% | ||
| Q2 25 | -2.0% | 13.8% | ||
| Q1 25 | -8.1% | 38.1% | ||
| Q4 24 | 3.3% | 44.4% | ||
| Q3 24 | 4.4% | 12.3% | ||
| Q2 24 | 4.5% | 7.0% | ||
| Q1 24 | 3.3% | 2.1% |
| Q4 25 | 3.8% | 7.8% | ||
| Q3 25 | 2.0% | 20.7% | ||
| Q2 25 | -2.7% | -7.3% | ||
| Q1 25 | -7.2% | 10.0% | ||
| Q4 24 | 1.5% | 23.9% | ||
| Q3 24 | 1.9% | -11.2% | ||
| Q2 24 | 2.0% | -0.5% | ||
| Q1 24 | 1.2% | -0.5% |
| Q4 25 | $0.35 | $2.34 | ||
| Q3 25 | $0.18 | $7.76 | ||
| Q2 25 | $-0.28 | $-2.95 | ||
| Q1 25 | $-0.74 | $3.33 | ||
| Q4 24 | $0.15 | $11.56 | ||
| Q3 24 | $0.18 | $-1.72 | ||
| Q2 24 | $0.19 | $-0.07 | ||
| Q1 24 | $0.12 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $185.6M |
| Total DebtLower is stronger | $45.0M | — |
| Stockholders' EquityBook value | $604.9M | $329.4M |
| Total Assets | $1.6B | $918.5M |
| Debt / EquityLower = less leverage | 0.07× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $185.6M | ||
| Q3 25 | $10.5M | $166.0M | ||
| Q2 25 | $7.8M | $96.7M | ||
| Q1 25 | $20.8M | $84.7M | ||
| Q4 24 | $10.2M | $40.6M | ||
| Q3 24 | $20.9M | $46.9M | ||
| Q2 24 | $18.7M | $40.8M | ||
| Q1 24 | $6.6M | $30.0M |
| Q4 25 | $45.0M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $71.5M | — | ||
| Q1 25 | $61.3M | — | ||
| Q4 24 | $59.3M | — | ||
| Q3 24 | $62.0M | — | ||
| Q2 24 | $112.0M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $604.9M | $329.4M | ||
| Q3 25 | $601.7M | $317.2M | ||
| Q2 25 | $604.9M | $235.3M | ||
| Q1 25 | $620.8M | $176.9M | ||
| Q4 24 | $648.9M | $132.4M | ||
| Q3 24 | $651.9M | $60.4M | ||
| Q2 24 | $654.4M | $62.7M | ||
| Q1 24 | $656.8M | $63.0M |
| Q4 25 | $1.6B | $918.5M | ||
| Q3 25 | $1.6B | $964.5M | ||
| Q2 25 | $1.6B | $841.0M | ||
| Q1 25 | $1.6B | $761.9M | ||
| Q4 24 | $1.7B | $655.3M | ||
| Q3 24 | $1.7B | $438.5M | ||
| Q2 24 | $1.7B | $422.4M | ||
| Q1 24 | $1.7B | $404.3M |
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.10× | — | ||
| Q4 24 | 0.09× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.17× | — | ||
| Q1 24 | 0.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $70.4M |
| Free Cash FlowOCF − Capex | $9.1M | $69.0M |
| FCF MarginFCF / Revenue | 3.1% | 45.5% |
| Capex IntensityCapex / Revenue | 3.0% | 0.9% |
| Cash ConversionOCF / Net Profit | 1.60× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $49.6M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $70.4M | ||
| Q3 25 | $32.3M | $99.5M | ||
| Q2 25 | $-1.9M | $27.3M | ||
| Q1 25 | $28.9M | $51.0M | ||
| Q4 24 | $14.8M | $54.0K | ||
| Q3 24 | $62.6M | $6.8M | ||
| Q2 24 | $25.6M | $13.3M | ||
| Q1 24 | $-5.3M | $3.1M |
| Q4 25 | $9.1M | $69.0M | ||
| Q3 25 | $26.6M | $99.2M | ||
| Q2 25 | $-9.3M | $26.5M | ||
| Q1 25 | $23.2M | $50.9M | ||
| Q4 24 | $7.9M | $-341.0K | ||
| Q3 24 | $57.6M | $6.2M | ||
| Q2 24 | $16.8M | $12.7M | ||
| Q1 24 | $-11.9M | $2.3M |
| Q4 25 | 3.1% | 45.5% | ||
| Q3 25 | 9.2% | 37.0% | ||
| Q2 25 | -3.1% | 10.9% | ||
| Q1 25 | 7.9% | 24.0% | ||
| Q4 24 | 2.6% | -0.1% | ||
| Q3 24 | 19.1% | 7.8% | ||
| Q2 24 | 5.7% | 16.7% | ||
| Q1 24 | -3.8% | 3.4% |
| Q4 25 | 3.0% | 0.9% | ||
| Q3 25 | 2.0% | 0.1% | ||
| Q2 25 | 2.5% | 0.3% | ||
| Q1 25 | 1.9% | 0.0% | ||
| Q4 24 | 2.2% | 0.2% | ||
| Q3 24 | 1.6% | 0.8% | ||
| Q2 24 | 3.0% | 0.7% | ||
| Q1 24 | 2.1% | 1.1% |
| Q4 25 | 1.60× | 5.95× | ||
| Q3 25 | 5.71× | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | 3.23× | 0.00× | ||
| Q3 24 | 11.08× | — | ||
| Q2 24 | 4.37× | — | ||
| Q1 24 | -1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MNRO
| Tires | $150.2M | 51% |
| Maintenance | $73.5M | 25% |
| Brakes | $35.1M | 12% |
| Steering | $24.9M | 8% |
| Batteries | $6.2M | 2% |
| Exhaust | $3.2M | 1% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
